Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo said last year it would pull its Levemir insulin from the U.S. market at the end of 2024, months after cutting its price by 65% to $108 a vial and $162 for a 5-pack of injector pens.

Madrid, Spain-based Insulcloud designed the device to monitor patient use of disposable insulin pens in real-time, increasing therapy adherence. The company said in a news release that the U.S.

This is not only a sustainability consideration but also a patient safety issue as insulin that has been stored incorrectly may not have the expected effect on blood glucose. I have had type 1 ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

The company said it would discontinue the insulin Levemir due to global manufacturing ... insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our ...

The global insulin pens market is witnessing unprecedented growth, propelled by the escalating prevalence of diabetes worldwide. According to recent industry reports, the market, valued at USD 35 ...

The first-of-its-kind study will be the first to evaluate closed-loop technology in people using Insulin Pens with Time-in-Range as a primary efficacy endpoint. SAN DIEGO, CA / ACCESSWIRE / October 23 ...

We couldn’t be happier to see Dr Sheila Reith, CBE honoured at the Pride of Britain Awards for improving the lives of millions of people with diabetes worldwide.

The first-of-its-kind study will be the first to evaluate closed-loop technology in people using Insulin Pens with Time-in-Range as a primary efficacy endpoint. SAN DIEGO, CA / ACCESSWIRE ...